Author details

Full Name

Pamela J Bjorkman

Affiliation

ORCID

Career Start Year

1979

Papers

286

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36658148	Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.		2023
37993719	Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.		2023
36718537	Viral immunity: Basic mechanisms and therapeutic applications-a Keystone Symposia report.		2023
37146611	ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines.		2023
36763635	CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.	Sci Immunol	2023
36747804	Structural characterization of HIV-1 Env heterotrimers bound to one or two CD4 receptors reveals intermediate Env conformations.		2023
36865256	Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology.		2023
37437570	Engineering RNA export for measurement and manipulation of living cells.	Cell	2023
36929749	Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics.		2023
35114110	Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display.	Cell Rep	2022
35960796	A naturally arising broad and potent CD4-binding site antibody with low somatic mutation.	Sci Adv	2022
35378752	Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models.		2022
35676279	Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals.	Nat Commun	2022
35857620	Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.	Science	2022
36448805	Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.	Journal of Virology	2022
35778473	Comparing methods for immobilizing HIV-1 SOSIPs in ELISAs that evaluate antibody binding.	Scientific Reports	2022
36597535	ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses.		2022
34990590	Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization.	Immunity	2022
34990486	B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.	PLoS Pathog	2022
35029310	Innovative vaccine approaches-a Keystone Symposia report.	Ann N Y Acad Sci	2022
34973165	Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.		2022
35165440	A gut-derived metabolite alters brain activity and anxiety behaviour in mice.	Nature	2022
35136084	Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer.	Nature Communications	2022
34374761	Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.	Clin Infect Dis	2022
34696536	How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika.	Viruses	2021
34234131	Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.	Nat Commun	2021
34015271	B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.	Cell	2021
33907745	Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.	bioRxiv	2021
34061185	The Evolution of Interdependence in a Four-Way Mealybug Symbiosis.	Genome Biology and Evolution	2021
33948592	Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.	bioRxiv	2021
33676971	Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.	Gastroenterology	2021
33782388	Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation.	Nature Communications	2021
33461210	Evolution of antibody immunity to SARS-CoV-2.	Nature	2021
33567448	mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.	Nature	2021
33831141	Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.	J Exp Med	2021
33661993	Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.	PLoS ONE	2021
33723514	characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2.	Molecular Therapy - Methods and Clinical Development	2021
33507235	Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.	Clinical Infectious Diseases	2021
33986172	Investigate the origins of COVID-19.	Science	2021
33767445	Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.	Nature	2021
33501451	mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.	bioRxiv	2021
33501434	Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.	bioRxiv	2021
33758864	Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.	bioRxiv	2021
33758856	Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.	bioRxiv	2021
33437043	Structural biology in the fight against COVID-19.	Nat Struct Mol Biol	2021
33436524	Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.	Science	2021
34345019	Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.	Nature	2021
34331873	Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.	Immunity	2021
33173867	Evolution of Antibody Immunity to SARS-CoV-2.	bioRxiv	2021
33217417	Lower Respiratory Tract Myeloid Cells Harbor SARS-Cov-2 and Display an Inflammatory Phenotype.	Chest	2021